These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 10964776)

  • 1. Expression of mutated poliovirus receptors in human neuroblastoma cells persistently infected with poliovirus.
    Pavio N; Couderc T; Girard S; Sgro JY; Blondel B; Colbère-Garapin F
    Virology; 2000 Sep; 274(2):331-42. PubMed ID: 10964776
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two amino acid substitutions in the type 3 poliovirus capsid contribute to the establishment of persistent infection in HEp-2c cells by modifying virus-receptor interactions.
    Duncan G; Pelletier I; Colbère-Garapin F
    Virology; 1998 Feb; 241(1):14-29. PubMed ID: 9454713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cell clones cured of persistent poliovirus infection display selective permissivity to the wild-type poliovirus strain Mahoney and partial resistance to the attenuated Sabin 1 strain and Mahoney mutants.
    Calvez V; Pelletier I; Couderc T; Pavio-Guédo N; Blondel B; Colbère-Garapin F
    Virology; 1995 Oct; 212(2):309-22. PubMed ID: 7571400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. One amino acid change on the capsid surface of poliovirus sabin 1 allows the establishment of persistent infections in HEp-2c cell cultures.
    Pelletier I; Duncan G; Colbère-Garapin F
    Virology; 1998 Feb; 241(1):1-13. PubMed ID: 9454712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Poliovirus-induced apoptosis is reduced in cells expressing a mutant CD155 selected during persistent poliovirus infection in neuroblastoma cells.
    Gosselin AS; Simonin Y; Guivel-Benhassine F; Rincheval V; Vayssière JL; Mignotte B; Colbère-Garapin F; Couderc T; Blondel B
    J Virol; 2003 Jan; 77(1):790-8. PubMed ID: 12477887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canyon rim residues, including antigenic determinants, modulate serotype-specific binding of polioviruses to mutants of the poliovirus receptor.
    Harber J; Bernhardt G; Lu HH; Sgro JY; Wimmer E
    Virology; 1995 Dec; 214(2):559-70. PubMed ID: 8553558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Host range of poliovirus is restricted to simians because of a rapid sequence change of the poliovirus receptor gene during evolution.
    Ida-Hosonuma M; Sasaki Y; Toyoda H; Nomoto A; Gotoh O; Yonekawa H; Koike S
    Arch Virol; 2003 Jan; 148(1):29-44. PubMed ID: 12536294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poliovirus receptor on human blood cells: a possible extraneural site of poliovirus replication.
    Freistadt MS; Fleit HB; Wimmer E
    Virology; 1993 Aug; 195(2):798-803. PubMed ID: 8393247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allele-specific adaptation of poliovirus VP1 B-C loop variants to mutant cell receptors.
    Liao S; Racaniello V
    J Virol; 1997 Dec; 71(12):9770-7. PubMed ID: 9371643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poliovirus mutants excreted by a chronically infected hypogammaglobulinemic patient establish persistent infections in human intestinal cells.
    Labadie K; Pelletier I; Saulnier A; Martin J; Colbère-Garapin F
    Virology; 2004 Jan; 318(1):66-78. PubMed ID: 14972536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poliovirus replication and spread in primary neuron cultures.
    Daley JK; Gechman LA; Skipworth J; Rall GF
    Virology; 2005 Sep; 340(1):10-20. PubMed ID: 16009390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse homolog of poliovirus receptor-related gene 2 product, mPRR2, mediates homophilic cell aggregation.
    Aoki J; Koike S; Asou H; Ise I; Suwa H; Tanaka T; Miyasaka M; Nomoto A
    Exp Cell Res; 1997 Sep; 235(2):374-84. PubMed ID: 9299162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Virus-receptor interaction in poliovirus entry and pathogenesis.
    Racaniello VR
    Harvey Lect; 1991-1992; 87():1-16. PubMed ID: 1670545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the poliovirus 147S particle: new insights into poliovirus uncoating.
    Pelletier I; Ouzilou L; Arita M; Nomoto A; Colbère-Garapin F
    Virology; 2003 Jan; 305(1):55-65. PubMed ID: 12504541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homolog-scanning mutagenesis reveals poliovirus receptor residues important for virus binding and replication.
    Morrison ME; He YJ; Wien MW; Hogle JM; Racaniello VR
    J Virol; 1994 Apr; 68(4):2578-88. PubMed ID: 8139037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced apoptosis in human intestinal cells cured of persistent poliovirus infection.
    Labadie K; Saulnier A; Martin-Latil S; Colbère-Garapin F
    J Virol; 2007 Mar; 81(6):3033-6. PubMed ID: 17192301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The poliovirus receptor: identification of domains and amino acid residues critical for virus binding.
    Bernhardt G; Harber J; Zibert A; deCrombrugghe M; Wimmer E
    Virology; 1994 Sep; 203(2):344-56. PubMed ID: 7914388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early events in poliovirus infection: virus-receptor interactions.
    Racaniello VR
    Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11378-81. PubMed ID: 8876143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth phenotypes and biosafety profiles in poliovirus-receptor transgenic mice of recombinant oncolytic polio/human rhinoviruses.
    Cello J; Toyoda H; Dejesus N; Dobrikova EY; Gromeier M; Wimmer E
    J Med Virol; 2008 Feb; 80(2):352-9. PubMed ID: 18098139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pyrimidine-rich region mutations compensate for a stem-loop V lesion in the 5' noncoding region of poliovirus genomic RNA.
    Stewart SR; Semler BL
    Virology; 1999 Nov; 264(2):385-97. PubMed ID: 10562500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.